Prof. Dr. Alain L. Fymat
Founding Chair, President/CEO and Institute Professor
Specialization: Neurodegenerative diseases (Alzheimer's, Parkinson's, dementias, epilepsy, and others), oncology (glioblastoma), epigenetics & ecogenetics, and nanomedicine & nanobiotechnology, and emerging infectious diseases.
Address: International Institute of Medicine and Science, California, U.S.A
DR. ALAIN L. FYMAT is a medical-physical scientist and an educator. He is the current President/ CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science. He was also Scientific Advisor to the U.S. National Academy of Sciences, National Research Council, for its postdoctoral programs tenable at the California Institute of Technology and Member of the Advisory Group for Research & Development, North Atlantic Treaty Organization (NATO). He is Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and Organizing Committee member at several international scientific/medical conferences. He has lectured extensively in the U.S.A, Canada, Europe, Asia, and Africa. He has published in excess of 525 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of numerous medical/scientific Journals to which he regularly contributes. He is a member of the New York Academy of Sciences and the European Union Academy of Sciences, a Board member of several institutions, and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. Dr. Fymat's current research interests are focused on neurodegenerative diseases (Alzheimer's, Parkinson's, dementias, epilepsy, and others), oncology (glioblastoma), epigenetics & ecogenetics, and nanomedicine & nanobiotechnology, and emerging infectious diseases. These are represented in part in his latest books: “The Odyssey of Humanity's Diseases: Epigenetic and ecogenetic modulations from ancestry through inheritance, environment, culture, and behavior” Volumes 1, 2, and 3; “From the Heart to the Brain: My collected works in medical science research (2016-2018)”; “The Human Brain: Wonders and Disorders”; “Alzhei ...Who? Demystifying the disease and what you can do about it”; “Parkin..ss..oo..nn: Elucidating the disease and what you can do about it”; “Dementia: Fending-off the menacing disease... and what you can do about it”; “Epilepsy: The electrical storm in te brain”; “Cancer:The pernicious clonally evolving disease braided in our genome”.; “Lyme disease: The great invader, evader, and imitator”; “Pandemics: Prescription for prediction and prevention”; “COVID-19: Perspectives across Africa”; “Multiple sclerosis: The progressive demyelinating autoimmune disease”.; and “Multiple System Atrophy”.